Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer
Lizhi Zhou(Southern Medical University), Weide Zhong(Macau University of Science and Technology), G. Chen(First Affiliated Hospital of Guangzhou Medical University), Qing-Qing Dai(First Affiliated Hospital of Guangzhou Medical University), Rujun Mo(First Affiliated Hospital of Guangzhou Medical University), Yue Zeng(Shandong University), Yun-Xia Chen(First Affiliated Hospital of Guangzhou Medical University), Hua He(First Affiliated Hospital of Guangzhou Medical University), Jian Zhu(Guizhou Provincial People's Hospital), Dan Xia(First Affiliated Hospital Zhejiang University), Yingying Liang(Guangzhou Medical University), Fan Jiang(Sun Yat-sen University)
Cited by 34
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
|OncoTargets and Therapy|2016|120
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
Association between cadmium exposure and renal cancer risk: a meta-analysis of observational studies
|Scientific Reports|2015|99
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
|Diabetes Research and Clinical Practice|2014|92